Considering the issue from an engineering perception, combined with a thoughtful understanding, it is evident that optical scattering spectroscopy and optical spectroscopy are the two imaging techniques that find their purpose in lung cancer detection devices. Manufacturing these equipments is a tough task. The party concerned has to appreciate the process involved in order to effectively manage the equipments (Reeves & Bednar, 2005). Thus, for an efficient outlook, it is important to comprehend that the polarized scattering spectroscopy imaging technique is based on the function of both the scattering and backscattering phenomena exhibited by the lungs. The most critical phase of this process is backscattering and is significantly aided by the fact that the lung tissues have cells whose component nucleuses refract light at the preferred angles and wavelength speeds as per the due refractive indices (Palcic and Hung, 1991). On the other hand, scattering is largely what leads to the divergence of the incident light as it is received by the system in the cancer detection (Kim, Liu and Backman, 2004). Both of these two critical aspects have to be understood in the correct perspective, in order to attain an enhanced outline of growth. For an irrefutable process, there is the optical spectroscopy, which is based on the pillars of scattering, fluorescence and assimilation interaction activities between the light and the lung tissue (Van, 2001). The combination of these processes results in the detection of human life marauder; lung cancer.
Given that this paper aims to highlight the best way of efficiently managing the product in terms of inventing the most workable marketing mix that is cost, there shall be a vital appreciation of the surroundings in which the product is to be exchanged (Gomez-Mejia et al., 2008). This can best be completed with the proper perceptive of the line of products that are dealt in first. Thus, the real purpose of the introduction is to set a clear tempo for what waits in the offing when the products have been produced and need to be marketed.
The products discussed in this paper which are majorly applied in the alleviation of the lung cancer threat, shall be best viable in South Africa where the prevalence of lung cancer cases are high. This is majorly because there are many tobacco smokers. Research has revealed that in the year 2006 alone the South Africa lost over 70,000 to cancer (Bello et al., 2011). This is a very high fatality rate to be recorded in only a year to a disease whose cure is not clear neither can it be ascertained. A greater part of the stated deaths was apparently men who accounted for over 60%. The market is therefore quite big with over 100,000 cases being reported in the past three months. (Bello et al., 2011). This has resulted in the occurrence rate skyrocketing from 30% to a whopping 40%. Therefore, the country especially the urban areas have individuals who remain exposed to the dangerous tobacco smoke. All these factors contribute to the need of the application of the devices dealt in. The business will definitely have a steady market to provide the actual products to a high a number. The producing company hopes to serve about 8 infected persons with one device. This huge number of respondents poses a challenge, as there are limited user manuals available. Thus, should the producing company seriously embark on the project; it shall not find much rivalry. In fact, the market is so ready that the benefits shall be notably massive. This number of those struggling with lung cancer is still likely to at least grow at an exponential pace based on the results of year 2006. The cases increased to about 20% in that year. Known that the situation have greatly changed and there is too much exposure to cancer causing agents, then the rates of the growth is going to be about 55% per annum. This is truly not an easy verdict when talking about the wellbeing of individuals. Thus, there is a need to have everything done in the best platform, to ensure progress. When well measured, the market shall be so ready that the returns for the company shall be corresponding to its expenses. It is noteworthy to realize that the method of operation of the devices that apply the technology is a bit involving hence requiring a very accurate application. The technology is also rather costly and not everyone can manage to pay for it. Consequently, the best tactic has been for the governments to come in and subsidize it for its residents (Kotter & Dan, 2002). This is the finest way to address this issue. It is founded on the pillar of collective measures as well as a plain understanding of what exactly is preferred. The fact that not so many individuals have trust in this technology hinders its entry into the market as a lifesaver.
The business atmosphere is at present endowed with not so positive factors. However, this perspective will soon change and the results will be worth the effort applied. The good news is that the technology currently in use is apparently cheaper but with out-of-date features that are to a large degree very sluggish. Whereas this technology can assure a fast feedback, the methods traditionally applied do take their time (Kotler & Kevin, 2009). Thus, this needs to be slowly and tactically considered. At the end of the day, there shall be a change courtesy of the adopted technology that applies to both optical spectroscopy and scattering technologies. These changes are expected to be competently considered to be a sign of on the already visible realities of having a clear way forward. In this quest, therefore, it is vital to note that the line of business requires an environment that has ready market for the products for constant flow. This not only avoids losses for the business enterprise but also ensures that there is not too much hoarding, which may obstruct the desired outcome of the earnings in sales. The anticipated situation for business is expected to be more responsive due to the effectiveness that is entrenched in the technology at hand. This needs to be done in such a way that many firms advocate the results.
A cost benefit examination is essential to ensure the clarity of what is being introduced into the market and to prove the practicability of the project as a whole. This also ensures that the firm remains competitive in its services without any disappointment (Keith, 1999). This comes about by ensuring stability. This analysis includes all the anticipated costs as well as reimbursement for every unit in the given market setting (Staehle, 1999). In this case, given that the firm is expected to make its way into the world, who stagger with the affordability of the technology, the cost benefit analysis shall be as illustrated below. In the same breath, here is the estimated cost benefit analysis for the task that is to be realized for 50,000 units in production:
| Year | Benefits (cumulated) ($) | Costs (cumulated) ($) | Net income ($) | Comment on income |
| 2012 | 35,250,000 | 35,500,000 | (250,000) | Adverse |
| 2013 | 50,375,250 | 41,650,000 | 8,725,250 | Favorable |
| 2014 | 53,000,000 | 44,000,000 | 9,000,000 | Favorable |
| 2015 | 55,500,000 | 45,000,000 | 10,500,000 | Favorable |
| 2016 | 64,125,000 | 43,450,000 | 20,675,000 | Favorable |
From the above analysis, there is a remarkable requirement to adopt the project, as it shall result in impressive returns after less than five years in terms of favorable earnings. In this evaluation, it has been assumed that the firm will manufacture not less than 50,000 units of the product. It is also assumed that the resultant sales are for at least 85% of the produced goods in that year of sale. Agreed that the charge of single lung cancer detection is at $800 (Early Cancer Detection, 2011), then the cost of manufacture per unit should not surpass $3,500 per device. This cost entails everything that needs to be included to have the best product. This is then approximated to be sold at a scope of 20% resulting to a selling price of $4,375. This margin needs to be maintained as predetermined by Henry (2003) who claims that good sales margins should not exceed 25%. He says that the margin that is within the 25% range doesn’t allocate for extortion. The cost of purchase is, therefore, manageable and may accrue some discounts in case of bulk purchase. This provides a good platform for the demand to be well catered for given that the target population is of standard income. The demand will equally improve the demand that results for the given spectroscopy detectors. This fact in mind, results in the basic reality of a progressive society with health being at its epicenter. Thus, given the returns of about 20% of the initial cost, the project is viable. It is equally assumed that the respective government, who form the vastness of the customer platform, shall intervene for the sake of its populace. This is in the accorded need to continue appreciating the benefits of having the lung cancer epidemic eagerly looked into to discover the most effective measures to implement. The business shall therefore be expected to be on the move with the due outcome being profitability. Courtesy of the understanding that accompanies the devices themselves, there is a resolution to have all of these transported by experienced people to avoid attracting nay unnecessary damages which may really translate into other costs (Aaker, 2008).
In conclusion, it is true that the project is readily viable considering the fact that it has the potential of resulting in not less than $5 million in net revenue if all is well done. Therefore, the business prospect should be adopted holistically. No failure should be tolerated but instead, all efforts should be invested in this venture so as to obtain the profits that are clearly available in addition to serving satisfying the customers. As long as this ensured, then the Polarized scattering spectroscopy and Optical spectroscopy shall be gladly adoptable as the line of commerce in the analysis of the lung cancer peril.
References
Aaker, D. (2008). Strategic Market Management. New York City: John Wiley and Sons.
Bello, B., Fadahun, O., Kielkowski, D. & Nelson, G. (2011). Trends in Lung Cancer Mortality in South Africa: 1995-2006. BMC Public Health. 11(1), 1-13.
Early Cancer Detection. (2011). Costs And How To Proceed.